Global Brain Tumor Diagnosis And Therapeutics Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI222900
- March 20, 2019
- Global
- 104 pages
- QY Market Research
Diagnosis of a brain tumor is done by a neurologic exam (by a neurologist or neurosurgeon), CT (computer tomography scan) and/or magnetic resonance imaging (MRI), and other tests like an angiogram, spinal tap and biopsy. Diagnosis helps predict the treatment. This report mainly stuides Brain Tumor Diagnosis and Therapeutics market.
CT scan segment held a lucrative revenue share in 2017 and is also likely to grow at a significant rate during the forecast period
The global Brain Tumor Diagnosis And Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Brain Tumor Diagnosis And Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Brain Tumor Diagnosis And Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Carestream Health
Merck & Co.
Astra Zeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics
Segment by Regions
North America
Europe
China
Japan
Segment by Type
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Segment by Application
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Table of Contents
Executive Summary
1 Brain Tumor Diagnosis And Therapeutics Market Overview
1.1 Product Overview and Scope of Brain Tumor Diagnosis And Therapeutics
1.2 Brain Tumor Diagnosis And Therapeutics Segment by Type
1.2.1 Global Brain Tumor Diagnosis And Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 MRI
1.2.3 CT Scan
1.2.4 Tissue Sampling
1.2.5 PET-CT Scan
1.2.6 Cerebral Arteriogram
1.2.7 Lumbar Puncture
1.2.8 Molecular Testing
1.2.9 EEG
1.3 Brain Tumor Diagnosis And Therapeutics Segment by Application
1.3.1 Brain Tumor Diagnosis And Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Surgery
1.3.3 Radiation Therapy
1.3.4 Chemotherapy
1.3.5 Immunotherapy
1.3.6 Targeted Therapy
1.4 Global Brain Tumor Diagnosis And Therapeutics Market by Region
1.4.1 Global Brain Tumor Diagnosis And Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Brain Tumor Diagnosis And Therapeutics Market Size
1.5.1 Global Brain Tumor Diagnosis And Therapeutics Revenue (2014-2025)
1.5.2 Global Brain Tumor Diagnosis And Therapeutics Production (2014-2025)
2 Global Brain Tumor Diagnosis And Therapeutics Market Competition by Manufacturers
2.1 Global Brain Tumor Diagnosis And Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Brain Tumor Diagnosis And Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Brain Tumor Diagnosis And Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Brain Tumor Diagnosis And Therapeutics Production Sites, Area Served, Product Types
2.5 Brain Tumor Diagnosis And Therapeutics Market Competitive Situation and Trends
2.5.1 Brain Tumor Diagnosis And Therapeutics Market Concentration Rate
2.5.2 ...
| read more...
Related Reports
